Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 5.238.608.177.076.05

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 5.23 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20255.23
Mar20248.60
Mar20238.17
Mar20227.07
Mar20216.05

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 5.23
-39.19
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07
16.86
Mar2021 6.05 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,078.0 Cr 0.3% 0.3% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,978.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 1.2% 10.2% 4.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.3%

0.3%

-19.6%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses